Cargando…
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198345/ https://www.ncbi.nlm.nih.gov/pubmed/35293148 http://dx.doi.org/10.1002/cac2.12282 |
| _version_ | 1784727593438674944 |
|---|---|
| author | Polonio‐Alcalá, Emma Solé‐Sánchez, Sònia Muñoz‐Guardiola, Pau Megías‐Roda, Elisabet Perez‐Montoyo, Héctor Yeste‐Velasco, Marc Alfón, Jose Lizcano, Jose Miguel Domènech, Carles Ruiz‐Martínez, Santiago Puig, Teresa |
| author_facet | Polonio‐Alcalá, Emma Solé‐Sánchez, Sònia Muñoz‐Guardiola, Pau Megías‐Roda, Elisabet Perez‐Montoyo, Héctor Yeste‐Velasco, Marc Alfón, Jose Lizcano, Jose Miguel Domènech, Carles Ruiz‐Martínez, Santiago Puig, Teresa |
| author_sort | Polonio‐Alcalá, Emma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9198345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91983452022-06-21 ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models Polonio‐Alcalá, Emma Solé‐Sánchez, Sònia Muñoz‐Guardiola, Pau Megías‐Roda, Elisabet Perez‐Montoyo, Héctor Yeste‐Velasco, Marc Alfón, Jose Lizcano, Jose Miguel Domènech, Carles Ruiz‐Martínez, Santiago Puig, Teresa Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-03-16 /pmc/articles/PMC9198345/ /pubmed/35293148 http://dx.doi.org/10.1002/cac2.12282 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Polonio‐Alcalá, Emma Solé‐Sánchez, Sònia Muñoz‐Guardiola, Pau Megías‐Roda, Elisabet Perez‐Montoyo, Héctor Yeste‐Velasco, Marc Alfón, Jose Lizcano, Jose Miguel Domènech, Carles Ruiz‐Martínez, Santiago Puig, Teresa ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title | ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title_full | ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title_fullStr | ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title_full_unstemmed | ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title_short | ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| title_sort | abtl0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198345/ https://www.ncbi.nlm.nih.gov/pubmed/35293148 http://dx.doi.org/10.1002/cac2.12282 |
| work_keys_str_mv | AT polonioalcalaemma abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT solesanchezsonia abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT munozguardiolapau abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT megiasrodaelisabet abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT perezmontoyohector abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT yestevelascomarc abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT alfonjose abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT lizcanojosemiguel abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT domenechcarles abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT ruizmartinezsantiago abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels AT puigteresa abtl0812enhancesantitumoreffectofpaclitaxelandrevertschemoresistanceintriplenegativebreastcancermodels |